eli lilly novo nordisk

Trump Jokes About Novo Nordisk and Lilly's U.S. Investments

What is TrumpRx? Deal with Eli Lilly, Novo Nordisk, Medicare on weight loss drug coverage

President Donald Trump announced a deal with Eli Lilly and Novo Nordisk to cut costs on their popular GLP-1 weight loss drugs — Wegovy and Zepbound.

· 2h · on MSN

Trump announces deal with Eli Lilly, Novo Nordisk to lower prices on obesity drugs

· 2h

Trump announces deal with Novo Nordisk and Eli Lilly

· 3h

Eli Lilly, Novo Nordisk Cut Weight-Loss Drug Prices in Deals With Trump Administration

Eli Lilly and Novo Nordisk are cutting prices for popular weight-loss drugs in deals struck with the Trump administration, which is expanding coverage of the drugs in the Medicare and Medicaid health-...

New Republic · 52m

Trump Exposes Who in White House Is on Ozempic

Wyoming News · 1h

Trump unveils deals to lower costs of some weight-loss drugs

IJR · 3h

Trump Announces $250 Weight Loss Drugs In Latest ‘TrumpRx’ Deal

Wegovy, currently priced at $1,350 per month, will cost $250, while Zepbound, currently priced at $1,080 per month, will cost $346.

· 3h

Trump makes deal to cut costs on popular obesity drugs

NBC Montana · 4h

Trump expected to announce deal to sell some weight loss drugs for $149 on TrumpRX

The American Journal of Managed Care

Trump Announces Deals With Eli Lilly, Novo Nordisk for Lower Weight Loss Drug Prices

Eli Lilly and Novo Nordisk will lower prices for GLP-1 receptor agonists, aligning with the Most Favored Nation executive order to address US drug pricing disparities. Novo Nordisk's semaglutide agents and Eli Lilly's tirzepatide will be significantly cheaper through TrumpRx, a new government platform launching in 2026.

3don MSN

Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech

The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.